Please use this identifier to cite or link to this item:
Title: Role of UPP pathway in amelioration of diabetes-associated complications
Authors: Gupta A
Behl T
Aleya L
Rahman M H
Yadav H N
Pal G
Kaur I
Arora S
Keywords: Diabetic cardiomyopathy
Diabetic neuropathy
Type 2 diabetes
Ubiquitin-proteasome pathway.
Issue Date: 2021
Publisher: Environmental Science and Pollution Research
Abstract: Type 2 diabetes (T2D) is one of the most widely spread metabolic disorder also called as "life style" disease. Due to the alarming number of patients, there is great need to therapies targeting functions which can help in maintaining the homeostasis of glucose levels and improving insulin sensitivity. Detailed analysis was done through various research and review papers which was searched using MEDLINE, BIOSIS, and EMBASE using various keywords. This search retrieved the most appropriate content on these molecules targeting UPP pathway. From this extensive review involving UPP pathway, it was concluded that the role of ubiquitin's is not only limited to neurodegenerative disorders but also plays a critical role in progression of diabetes including obesity, insulin resistance, and various neurogenerative disorders but it also targets proteasomal degradation including mediation of cellular signaling pathways. Thus, drugs targeting UPP not only may show effect against diabetes but also are therapeutically beneficial in the treatment of diabetes-associated complications which may be obtained. Thus, based on the available information and data on UPP functions, it can be concluded that regulation of UPP pathway via downstream regulators mainly E1, E2, and E3 may bring promising results. Drugs targeting these transcriptional factors may emerge as a novel therapy in the treatment of diabetes and diabetes-associated complications.
URI: 10.1007/s11356-021-12781-5
Appears in Collections:Journals

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.